News about Market

Arima Genomics Partners with Active Motif to Expand Global Access to Hi-C Research Solutions

Arima Genomics has granted Active Motif exclusive distribution rights for its Hi-C research kits and services, supporting broader adoption of 3D genomics tools while advancing Arima's clinical cancer diagnostics strategy.

Market | 06/07/2026 | By News Bureau

Sofinnova Partners Announces Myricx Bio Agrees to Be Acquired by Novartis

Sofinnova Partners announced that portfolio company Myricx Bio has agreed to be acquired by Novartis, strengthening the company's oncology pipeline and ADC capabilities.

Market | 06/07/2026 | By Akanki

Emcure's Marcan Pharma to Acquire Remaining Stake in Mantra Pharma

Emcure Pharmaceuticals' subsidiary Marcan Pharmaceuticals has signed agreements to acquire the remaining Class E Special Shares of Canada's Mantra Pharma, making the company a wholly owned subsidiary.

Market | 06/07/2026 | By News Bureau

Oliva Therapeutics to Commercially Launch Amerithroid for Hypothyroidism Treatment

Oliva Therapeutics is set to launch Amerithroid, a US-manufactured desiccated thyroid extract developed in partnership with Jerome Stevens Pharmaceuticals, strengthening its endocrine care portfolio with a naturally derived treatment for hypothyroidism.

Market | 06/07/2026 | By News Bureau

Glenmark Pharmaceuticals Launches Olanzapine for Injection 10 mg/vial Single-Dose Vial in US

Glenmark Pharmaceuticals Inc., USA has launched Olanzapine for Injection 10 mg/vial, a bioequivalent and therapeutically equivalent generic to Zyprexa IntraMuscular Injection.

Market | 06/07/2026 | By Akanki

Samsung Bioepis Relaunches Byooviz in US Through Commercial Partnership with Harrow

Samsung Bioepis has relaunched its ophthalmology biosimilar Byooviz in the US through its partnership with Harrow, expanding access to a lower-cost treatment option for patients with retinal diseases, including wet age-related macular degeneration.

Market | 03/07/2026 | By News Bureau

Mankind Pharma Partners with Denovo Sciences to Accelerate AI-Driven Drug Discovery

The collaboration between Mankind Pharma and Denovo Sciences launches AI-powered drug discovery to accelerate research timelines and improve lead candidate quality.

Market | 02/07/2026 | By News Bureau

Innovent and Lilly Partner to Commercialise Verzenios in China

Innovent Biologics and Eli Lilly have signed a commercialisation agreement for Verzenios (abemaciclib) in mainland China, expanding access to the CDK4/6 inhibitor for cancer patients.

Market | 01/07/2026 | By News Bureau

Jagsonpal Pharmaceuticals to Acquire 85 Percent Stake in Aequitas Healthcare for INR 20.8 Crore

Aeguitas Healthcare’s acquisition marks Jagsonpal's entry into the hospital pharmaceutical segment, strengthening its omnichannel healthcare strategy and expanding its institutional market presence.

Market | 01/07/2026 | By News Bureau

Cadila Pharmaceuticals, Wellesta Forge Joint Venture to Expand Healthcare Footprint Across Southeast Asia

Cadila Pharmaceuticals and Singapore-based Wellesta Holdings have signed an MoU to establish a joint venture focused on expanding access to high-quality healthcare solutions across Southeast Asia and other emerging markets.

Market | 01/07/2026 | By News Bureau